25,000 Encompass Health Corporation $EHC Shares Bought by Sivik Global Healthcare LLC

Sivik Global Healthcare LLC grew its stake in Encompass Health Corporation (NYSE:EHC) by 166.7% during the third quarter, HoldingsChannel.com reports. The firm owned 40,000 shares of the company’s stock after purchasing an additional 25,000 shares during the period. Encompass Health makes up approximately 3.0% of Sivik Global Healthcare LLC’s holdings, making the stock its 16th biggest holding. Sivik Global Healthcare LLC’s holdings in Encompass Health were worth $4,860,000 as of its most recent filing with the SEC.

Several other large investors have also modified their holdings of EHC. Ancora Advisors LLC purchased a new position in Encompass Health during the 2nd quarter worth approximately $10,639,000. Canada Pension Plan Investment Board purchased a new position in shares of Encompass Health during the second quarter valued at $7,723,000. Oppenheimer Asset Management Inc. purchased a new position in shares of Encompass Health during the second quarter valued at $2,620,000. VELA Investment Management LLC raised its position in Encompass Health by 53.6% during the second quarter. VELA Investment Management LLC now owns 48,991 shares of the company’s stock valued at $4,952,000 after buying an additional 17,105 shares during the period. Finally, Deutsche Bank AG acquired a new position in Encompass Health during the second quarter valued at $1,285,000. Institutional investors own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. UBS Group raised their price objective on Encompass Health from $150.00 to $155.00 and gave the stock a “buy” rating in a research report on Friday, August 7th. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a report on Saturday, September 26th. Barclays increased their price target on shares of Encompass Health from $140.00 to $144.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. TD Cowen raised their price target on shares of Encompass Health from $125.00 to $140.00 and gave the stock a “buy” rating in a report on Monday, August 10th. Finally, Raymond James Financial set a $150.00 target price on shares of Encompass Health in a research report on Monday, September 28th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $148.50.

Insider Activity

In other news, CEO Mark Tarr sold 173,148 shares of the company’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the completion of the transaction, the chief executive officer owned 267,814 shares of the company’s stock, valued at approximately $33,602,622.58. This represents a 39.27% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP John Darby sold 8,906 shares of the stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $125.95, for a total transaction of $1,121,710.70. Following the completion of the sale, the executive vice president owned 75,041 shares of the company’s stock, valued at approximately $9,451,413.95. The trade was a 10.61% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 186,912 shares of company stock worth $23,434,845. Insiders own 1.80% of the company’s stock.

Encompass Health Stock Up 0.3%

Shares of NYSE:EHC traded up $0.34 on Tuesday, reaching $124.76. The company had a trading volume of 139,999 shares, compared to its average volume of 1,035,778. Encompass Health Corporation has a twelve month low of $92.77 and a twelve month high of $127.99. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.76. The stock has a 50-day moving average price of $121.81 and a 200 day moving average price of $110.85. The stock has a market capitalization of $12.31 billion, a P/E ratio of 20.32, a P/E/G ratio of 2.50 and a beta of 0.74.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Wednesday, August 5th. The company reported $1.55 EPS for the quarter, beating analysts’ consensus estimates of $1.48 by $0.07. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. The company had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.57 billion. During the same quarter last year, the firm posted $1.40 earnings per share. The company’s quarterly revenue was up 9.6% compared to the same quarter last year. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. On average, equities analysts expect that Encompass Health Corporation will post 6.08 EPS for the current year.

Encompass Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Thursday, October 1st. This is a positive change from Encompass Health’s previous quarterly dividend of $0.19. Encompass Health’s payout ratio is presently 13.68%.

About Encompass Health

Encompass Health Corporation (NYSE:EHC) is a healthcare services company focused on inpatient rehabilitation. Through its network of rehabilitation hospitals, the company provides intensive medical and therapeutic care to patients recovering from conditions such as strokes, brain and spinal cord injuries, hip fractures, amputations, neurological disorders, and other disabling illnesses or injuries.

Its rehabilitation hospitals offer coordinated care from physicians, nurses, therapists, and other healthcare professionals.